Skip to main content
News Tag: news
Trial Adding Relatlimab to Immunotherapy for Recurrent or Metastatic Nasopharyngeal Cancer Activates (NRG-HN011)
Read More
NRG Activates Phase II Study for AR-Positive Ovarian Granulosa Cell Tumors (NRG-GY033)
Read More
FORTE: National Cancer Prevention Month 2024
Read More
PI Interview: The NRG-CC010 Study for SLN Mapping on Patient-Reported Lower Extremity Limb Dysfunction in Endometrial Cancer
Read More
PI Interview: The NRG-CC008 (SOROCk) Study Comparing Two Surgical Procedures for Women with BRCA1 Mutations to Assess Risk Reduction for Ovarian Cancer
Read More
NRG Oncology and the University of Pittsburgh demonstrate that a Machine Learning Model Predicts Oxaliplatin Benefit Using Data from Two NSABP Clinical Trials
Read More
NRG Oncology Selects Health Equity Fellows for 2024
Read More
A Message from the Chairs of NRG Oncology’s Research Strategy Committee
Read More
The FORTE Workshop is coming soon…
Read More
PSC Continuing Education Sessions at #NRG2024
Read More